Lipocine inc. (LPCN)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Sep'12Dec'11
Revenues:
License revenue

164

428

0

0

-

-

-

-

-

-

License revenue

-

-

-

-

-

-

-

7,523

-

-

Research revenue

-

-

-

-

-

-

-

186

-

-

Total revenues

164

428

0

0

-

-

-

7,709

0

0

Operating expenses:
Research and development

7,468

6,464

11,004

8,076

12,580

15,479

5,122

2,281

-

-

Filing fees

-

-

-

-

-

-

-

-

7

1

Professional fees

-

-

-

-

-

-

-

-

33

2

Consulting fees

-

-

-

-

-

-

-

-

33

0

Incorporation

-

-

-

-

-

-

-

-

0

0

Franchise tax expense

-

-

-

-

-

-

-

-

0

0

Other

-

-

-

-

-

-

-

-

0

0

General and administrative

5,597

5,289

10,213

10,382

5,801

5,001

3,635

1,551

76

5

Restructuring costs

-

-

0

728

0

0

-

-

-

-

Reverse merger costs

-

-

-

-

-

-

1,011

0

-

-

Settlement for termination of certain rights in stock purchase agreement

-

-

-

-

-

-

913

0

-

-

Total operating expenses

13,065

11,753

21,217

19,186

18,382

20,480

10,683

3,832

-

-

Operating loss

-12,900

-11,325

-21,217

-19,186

-18,382

-20,480

-10,683

3,877

-

-

Other income (expense):
Total other expense, net

-343

-333

235

216

-

-

-

-

-

-

Unrealized loss on warrant liability

236

0

-

-

-

-

-

-

-

-

Other income, net

-

-

-

-

173

108

38

10

-

-

Loss before income tax expense

-13,007

-11,659

-20,982

-18,970

-18,208

-20,372

-10,645

3,887

-

-

Income tax expense

0

0

0

0

0

0

-55

0

-

-

(Loss) from Operations

-

-

-

-

-

-

-

-

-76

-5

Provision for income taxes

-

-

-

-

-

-

-

-

0

0

Net loss

-13,007

-11,660

-20,982

-18,971

-18,208

-20,372

-10,590

3,886

-76

-5

Basic loss per share attributable to common stock

-0.50

-0.55

-1.05

-1.04

-1.11

-1.60

-1.44

0.85

-

-

Weighted average common shares outstanding, basic

25,882

21,352

20,051

18,258

16,470

12,766

7,363

4,455

-

-

Diluted loss per share attributable to common stock

-0.50

-0.55

-1.05

-1.04

-1.11

-1.60

-1.44

0.85

-

-

Weighted average common shares outstanding, diluted

25,882

21,352

20,051

18,258

16,470

12,766

7,363

4,455

-

-

Comprehensive loss:
Net loss

-13,007

-11,660

-20,982

-18,971

-18,208

-20,372

-10,590

3,886

-76

-5

Net unrealized gain on available-for-sale securities

0

3

3

24

-32

0

-

-

-

-

Comprehensive loss

-13,006

-11,656

-20,978

-18,947

-18,241

-20,372

-10,590

3,886

-

-

(Loss) per common share - Basic and Diluted

-

-

-

-

-

-

-

-

-

0.00

Weighted Average Number of Common Shares Outstanding - Basic and Diluted

-

-

-

-

-

-

-

-

-

1,800